NCT03237156View on ClinicalTrials.gov

Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

October 7, 2017

Study Completion Date

October 7, 2017

Conditions
Japanese Healthy Adult Male Participants
Interventions
DRUG

TAK-906

TAK-906 capsules.

DRUG

TAK-906 Placebo

Placebo capsules.

Trial Locations (1)

Unknown

Sekino Clinical Pharmacology Clinic, Toshima City

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03237156 - Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants | Biotech Hunter | Biotech Hunter